Michael A. Brannan - 20 Jan 2022 Form 4 Insider Report for AEHR TEST SYSTEMS (AEHR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Jan 2022, 15:00:58 UTC
Prior SEC filing
14 Jan 2022
Next SEC filing
27 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael A. Brannan

Key filing fact

Michael A. Brannan filed Form 4 for AEHR TEST SYSTEMS (AEHR) on 24 Jan 2022.

Key facts

  • This page summarizes Michael A. Brannan's Form 4 filing for AEHR TEST SYSTEMS (AEHR).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Jan 2022, 15:00.

Change

  • Previous filing in this sequence was filed on 14 Jan 2022.
  • Current net transaction value: -$185,803.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AEHR transaction

Common Stock

Options Exercise

Transaction value
$3,812
Shares
+3,125
Change %
+11%
Price
$1.22*
Shares after
31,723
Date
20 Jan 2022
Ownership
Direct
AEHR transaction

Common Stock

Sale

Transaction value
$189,615
Shares
-15,350
Change %
-48%
Price
$12.35
Shares after
16,373
Date
20 Jan 2022
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AEHR transaction Derivative

Incentive Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-3,125
Change %
-7.1%
Price
$0.000000
Shares after
40,625
Date
20 Jan 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,125
Exercise price
$1.22
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.20 to $12.66, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

Footnote F2

The amount reported includes shares subject to unvested restricted stock units.

Footnote F3

One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .